$41.59
-0.25[-0.60%]
At close: Apr 26
$41.59
0[0.00%]
After Hours: 4:20PM EDT
Ionis Pharmaceuticals
(NASDAQ:IONS)Ionis Pharmaceuticals Stock (NASDAQ:IONS), Insider Trading Activity
Ionis Pharmaceuticals: Insider buying and selling updated today.
Insider Shares Owned
1.361M
Insider Percentage Owned
0.93%
Institutional Shares Held
112.700M
Institutional Percentage Held
77.3%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17, 2024 | Joseph Baroldi | EVP, CHIEF BUSINESS OFFICER | 6.832K | $41.60 | -$166.64K | SELL-OPTIONS | 47.32% | 21.271K | Apr 15 - Apr 16 | View |
| Apr 17, 2024 | Brian Birchler | EVP, CORP AND DEVELOPMENT OPS | 970 | $41.66 | -$37.70K | SELL-OPTIONS | 2.15% | 46.156K | Apr 15 - Apr 16 | View |
| Feb 16, 2024 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -387 | $44.49 | -$17.22K | SELL | -0.22% | 173.751K | Feb 16 | View |
| Feb 02, 2024 | Eric Swayze | EVP RESEARCH | -8.965K | $51.63 | -$654.71K | SELL | -20.67% | 34.409K | Jan 31 - Feb 02 | View |
| Feb 02, 2024 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 1.962K | $49.59 | -$102.70K | GRANT | 4.10% | 49.812K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 1.859K | $49.67 | -$97.41K | GRANT | 3.97% | 48.661K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 22.287K | $49.37 | -$1.16M | GRANT | 14.68% | 174.138K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | Elizabeth L Hougen | EVP, FINANCE & CFO | 2.015K | $49.54 | -$105.27K | GRANT | 2.22% | 92.905K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 1.859K | $50.04 | -$98.13K | GRANT | 2.17% | 87.334K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | Onaiza Cadoret-Manier | EVP, CHF GL PDT STR & OPER OFC | 2.015K | $49.60 | -$105.40K | GRANT | 5.96% | 35.825K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 1.756K | $49.52 | -$91.75K | GRANT | 2.27% | 79.079K | Feb 01 - Feb 02 | View |
| Jan 29, 2024 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -2.285K | $51.75 | -$118.25K | SELL | -1.48% | 151.851K | Jan 25 | View |
| Jan 29, 2024 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | -6.45K | $51.75 | -$333.79K | SELL | -12.11% | 46.802K | Jan 25 | View |
| Jan 18, 2024 | Onaiza Cadoret-Manier | EVP, CHF GL PDT STR & OPER OFC | 9.498K | $50.42 | -$280.52K | SELL-OPTIONS | 39.07% | 33.81K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 12.897K | $50.42 | -$390.43K | SELL-OPTIONS | 31.96% | 53.252K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Brian Birchler | EVP, CORP AND DEVELOPMENT OPS | 7.583K | $50.42 | -$226.73K | SELL-OPTIONS | 20.50% | 44.582K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Eric Swayze | EVP RESEARCH | 10.785K | $50.42 | -$317.88K | SELL-OPTIONS | ∞ | 85 | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 9.68K | $50.42 | -$276.39K | SELL-OPTIONS | 25.36% | 47.85K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 36.025K | $50.42 | -$1.62M | SELL-OPTIONS | 30.50% | 154.136K | Jan 16 - Jan 17 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.